Please Wait

Applying Filters...

5 FU Medac
USDMF
Table View

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

5 FU medac

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 15 USDMF, 4 CEP/COS, 2 JDMF, 14 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

103 Drugs in Development

103 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

170 FDF Dossiers, 69 FDA Orange Book, 42 Europe, 6 Canada, 28 Australia, 11 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;TOPICAL - 2%, SOLUTION;TOPICAL - 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.5%, CREAM;TOPICAL - 4%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 SPI Pharma, 10 DKSH, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Actylis, 10 BASF, 1 BioSpectra, 1 Clariant, 2 Corel Pharma Chem, 2 Finar, 6 Gangwal Chemicals, 7 Kerry, 2 Lubrizol Life Science Health, 3 Microlex e.U, 2 Nanjing Bold Chemical, 1 Pluviaendo, 4 Roquette, 9 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Topical, 22 Solubilizers, 15 Parenteral, 11 Film Formers & Plasticizers, 10 Emulsifying Agents, 10 Thickeners and Stabilizers, 10 Fillers, Diluents & Binders, 9 Coating Systems & Additives, 7 Surfactant & Foaming Agents, 6 Co-Processed Excipients, 4 Direct Compression, 4 Lubricants & Glidants, 3 Rheology Modifiers, 2 Granulation, 2 Controlled & Modified Release, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 40 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 46 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

15 APIs, 15 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM, 5 USP, 6 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	Actylis	U.S.A	PHARMA-WALDHOF GMBH	4959	5-FLUORO-URACIL,PRODUCT 4965	1983-05-18	Inactive	II	N/A
28/03/2025	Amcol	U.S.A	AMCOL HEALTH AND BEAUTY SOLUTIONS INC	29443	POLY-PORE® FLUOROURACIL POLYMER	2015-11-13	Active	II	Complete	2017-07-07	2015-07-08

Contact us
to update this info

5 FU Medac

5 FU medac

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers

15 USDMF

4 CEP/COS

2 JDMF

14 NDC API

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

103 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

170 FDF Dossiers

69 FDA Orange Book

42 Europe

6 Canada

28 Australia

11 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;TOPICAL - 2%

SOLUTION;TOPICAL - 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.5%

CREAM;TOPICAL - 4%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 SPI Pharma

10 DKSH

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

5 Actylis

10 BASF

1 BioSpectra

1 Clariant

2 Corel Pharma Chem

2 Finar

6 Gangwal Chemicals

7 Kerry

2 Lubrizol Life Science Health

3 Microlex e.U

2 Nanjing Bold Chemical

1 Pluviaendo

4 Roquette

9 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Topical

22 Solubilizers

15 Parenteral

11 Film Formers & Plasticizers

10 Emulsifying Agents

10 Thickeners and Stabilizers

10 Fillers, Diluents & Binders

9 Coating Systems & Additives

7 Surfactant & Foaming Agents

6 Co-Processed Excipients

4 Direct Compression

4 Lubricants & Glidants

3 Rheology Modifiers

2 Granulation

2 Controlled & Modified Release

1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

40 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

46 Regulatory FDF Prices

1 Annual Reports

MARKET PLACE

15 APIs

15 FDF Dossiers

REF. STANDARDS & IMPURITIES

SOLUTION;TOPICAL - 5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons